Impact of Different Types of Higher Dietary Protein Intake on Sleep Quality in Singapore Older Adults
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 54
- 试验地点
- 2
- 主要终点
- Change in sleep quality assessed by electronic equipment
研究概览
简要总结
Today, insufficient sleep has become a growing global problem. Sleep is essential to health and changes in sleep patterns are a part of the aging process. Inadequate and low-quality sleep also increases the risk for age-related cognitive decline and disease conditions. More importantly, due to COVID-19 health emergency, there is a significant increase of psychological distress and symptoms of mental illness and a worsening of quality of sleep. Therefore, there is an urgent need to investigate the way of improving sleep quality, in particular during and post COVID-19 period, in older adults.
One of the possible strategies in improving sleep quality with lifestyle modification is having higher-protein diet. However, this effect has not been fully elucidated in older adults. In addition, the effect of type of dietary protein on sleep quality is inconclusive and there is no clinical trial which assessed the differential response in sleep quality between animal-sourced protein vs. plant-sourced protein. Therefore, the purpose of this research project is to assess the impact of different types of higher dietary protein intake on sleep quality in Singapore older adults.
Findings from the proposed research will provide the scientific evidence of the beneficial effects of regularly consuming higher-protein diet on sleep quality in Singapore older adults. In addition, this research may validate the differential effect of different type of dietary protein on sleep quality. The results from the proposed research will also assist a practical guidance of nutritional behaviour changes providing sleep promoting effects to a large proportion of the Singapore population.
详细描述
During the 16-week intervention, subjects will be randomly assigned to 1 of 3 groups including consuming normal-protein diet, higher-protein diet supplemented with micellar casein protein or higher-protein diet supplemented with soy protein. Recommended Dietary Allowances for healthy Singaporean. Normal-protein diet will be designed following a healthy eating pattern diet, referred to as the "My Healthy Plate" launched by Health Promotion Board and subjects will consume 3 servings of dietary protein. Higher-protein diet will also follow a healthy eating pattern diet while subjects will additionally take either 20 g micellar casein protein isolate or 20 g soy protein isolate. One-on-one dietary counselling and written instructions for each subject will be provided by a research dietitian and trained research staff. Compliance with the diet interventions will be promoted by frequent online and in-person contact and dietary assessment. Blood amino acid concentration will also be assessed as an indicator of compliance to the protein intake.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Basic Science
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 60 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adults 60-85 years old
- •Not following HPB diet
排除标准
- •Weight change > 3kg in the past 3 months
- •Exercise vigorously over the past 3 months
- •Drinking more than 2 alcoholic drinks per day
- •(if applicable) Pre-menopausal women
- •Taking dietary supplements or medications which may impact sleep outcomes (e.g. Nutritional Shakes (e.g. Ensure), Trp, 5-HTP or melatonin supplementations) the past 1 month
- •Taking dietary supplements which may impact the gut microbiota (e.g. antibiotics, prebiotics, probiotics) the past 2 months (a list of fermented foods)
- •Impaired renal function (normal values: estimated glomerular filtration rate ≥ 90 mL/min/1.73 m2 calculated by chronic kidney disease epidemiology collaboration equation; CKD EPI)
- •Soy intolerance and/or allergy or any medical conditions that may be affected by consumption of soy products (e.g. gout)
- •Prescribed and taking antihypertensive/cholesterol-lowering/ type-2 diabetic medication or Chinese medicine herb which started less than 3 years prior to the intervention participation
- •Diagnosed with gut/gastrointestinal issues such as lactose intolerance and irritable bowel syndrome (IBS)
结局指标
主要结局
Change in sleep quality assessed by electronic equipment
时间窗: Every 4 weeks (week 0, week 4, week 8, week 12 and week 16)
An electronic equipment, actigraphy, will be used to assess the sleep quality, including sleep timing and wake up timing.
Change in blood serotonin concentration
时间窗: Every 8 weeks (week 0 , week 8 and week 16)
Serotonin concentration in the blood will be measured
Change in sleep quality assessed by validated sleep questionnaires
时间窗: Every 4 weeks (week 0, week 4, week 8, week 12 and week 16)
Pittsburgh Sleep Quality Index Questionnaire (PSQI) will be used to assess the sleep quality. Overall score ranging from 0 to 21 points, where lower scores denote a healthier sleep quality.
Change in blood amino acid concentration
时间窗: Every 8 weeks (week 0 , week 8 and week 16)
Amino acid concentration in the blood will be measured
Change in urinary 6-sulfatoxymelatonin (aMT6s) concentration
时间窗: Every 8 weeks (week 0 , week 8 and week 16)
6-sulfatoxymelatonin (aMT6s) concentration in the urine samples will be measured
次要结局
- Change in fecal short chain fatty acid (SCFA) concentration(Every 8 weeks (week 0 , week 8 and week 16))
- Change in blood short chain fatty acid (SCFA) concentration(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Trimethylamine N-oxide (TMAO)(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Skin Advanced Glycation End-product (AGEs)(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Flow Mediate Dilation(Baseline and Post-intervention (week 0 and week 16))
- Change in urinary creatinine concentration(Every 8 weeks (week 0 , week 8 and week 16))
- Change in serum lipopolysaccharide binding protein (LBP) concentration(Every 8 weeks (week 0 , week 8 and week 16))
- Change in fecal bile acids(Every 8 weeks (week 0 , week 8 and week 16))
- Change in fecal calprotectin(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Blood Triglyceride(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Blood Cholesterol(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Blood Low-density Lipoprotein-cholesterol (LDL)(Every 8 weeks (week 0 , week 8 and week 16))
- Change in fecal microbiome composition(Every 8 weeks (week 0 , week 8 and week 16))
- Change in fecal zonulin(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Blood High-density Lipoprotein-cholesterol (LDL)(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Endothelial Function(Baseline and Post-intervention (week 0 and week 16))
- Change in mood (depression)(Every 4 weeks (week 0, week 4, week 8, week 12 and week 16))
- Change in Estimated Glomerular Filtration Rate (eGFR)(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Blood Glucose(Every 8 weeks (week 0 , week 8 and week 16))
- Change in Blood Advanced Glycation End-product (AGEs)(Every 8 weeks (week 0 , week 8 and week 16))
- Change in blood pressure(Every 4 weeks (week 0, week 4, week 8, week 12 and week 16))
- Change in Blood Interleukin-6 (IL-6)(Every 8 weeks (week 0 , week 8 and week 16))
- Change in weight and height(Every 4 weeks (week 0, week 4, week 8, week 12 and week 16))
- Change in waist circumference(Every 4 weeks (week 0, week 4, week 8, week 12 and week 16))
- Change in mood (stress)(Every 4 weeks (week 0, week 4, week 8, week 12 and week 16))
- Change in mood (anxiety)(Every 4 weeks (week 0, week 4, week 8, week 12 and week 16))
- Dietary assessment(Every 4 weeks (week 0, week 4, week 8, week 12 and week 16))
研究者
Jung Eun Kim
Assistant Professor
National University of Singapore